The investment seeks to provide capital appreciation... Show more
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category ConsumerDiscretionary
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| IJPIX | 16.64 | 0.39 | +2.40% |
| VY® JPMorgan Emerging Markets Equity S | |||
| VSNGX | 69.90 | -0.18 | -0.26% |
| JPMorgan Mid Cap Equity I | |||
| JSIGX | 22.57 | -0.13 | -0.57% |
| Jacob Small Cap Growth Institutional | |||
| ETAHX | 53.90 | -0.88 | -1.61% |
| Eventide Healthcare & Life Sciences A | |||
| GLDIX | 41.59 | -1.24 | -2.90% |
| Gabelli Gold I | |||
A.I.dvisor indicates that over the last year, RYLSX has been closely correlated with USLUX. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if RYLSX jumps, then USLUX could also see price increases.
| Ticker / NAME | Correlation To RYLSX | 1D Price Change % | ||
|---|---|---|---|---|
| RYLSX | 100% | -1.00% | ||
| USLUX - RYLSX | 79% Closely correlated | -0.38% | ||
| FSCPX - RYLSX | 1% Poorly correlated | +2.94% | ||
| VCDAX - RYLSX | -0% Poorly correlated | +2.69% | ||
| FSHOX - RYLSX | -1% Poorly correlated | +0.34% | ||
| FSRPX - RYLSX | -4% Poorly correlated | +3.02% | ||
More | ||||